Abstract:BackgroundAppreciable evidence suggest that dysbiosis in microbiota, reflected in gut microbial imbalance plays a key role in the pathogenesis of neuropsychiatric disorders including depression and inflammatory diseases. Recently, the antidepressant properties of ketamine have gained prominence due to its fast and long lasting effects. Additional uses for ketamine in inflammatory disorders such as irritable bowel syndrome have been suggested. However, ketamine’s exact mechanism of action and potential effects on microbiome is not known. Here, we examined the effects of low dose ketamine, known to induce antidepressant effects, on stool microbiome profile in adult male Wistar rats. Animals (5/group) were injected intraperitoneally with ketamine (2.5 mg/kg) or saline, daily for 7 days and sacrificed on day 8 when intestinal stools were collected and stored at − 80 °C. DNA was extracted from the samples and the 16 S rRNA gene-based microbiota analysis was performed using 16S Metagenomics application.ResultsAt genus–level, ketamine strikingly amplified Lactobacillus, Turicibacter and Sarcina by 3.3, 26 and 42 fold, respectively. Conversely, opportunistic pathogens Mucispirillum and Ruminococcus were reduced by approximately 2.6 and 26 fold, respectively, in ketamine group. Low levels of Lactobacillus and Turicibacter are associated with various disorders including depression and administration of certain species of Lactobacillus ameliorates depressive-like behavior in animal models. Hence, some of the antidepressant effects of ketamine might be mediated through its interaction with these gut bacteria. Additionally, high level of Ruminococcus is positively associated with the severity of irritable bowel syndrome (IBS), and some species of Mucispirillum have been associated with intestinal inflammation. Indirect evidence of anti-inflammatory role of Sarcina has been documented. Hence, some of the anti-inflammatory effects of ketamine and its usefulness in specific inflammatory diseases including IBS may be mediated through its interaction with these latter bacteria.ConclusionOur data suggest that at least some of the antidepressant and anti-inflammatory effects of daily ketamine treatment for 7 days may be mediated via its interaction with specific gut bacteria. These findings further validate the usefulness of microbiome as a target for therapeutic intervention and call for more detailed investigation of microbiome interaction with central mediators of mood and/or inflammatory disorders.

Impact of Altered Gut Microbiota on Ketamine-Induced Conditioned Place Preference in Mice

Exploring the role and mechanism of gut microbiota in methamphetamine addiction using antibiotic treatment followed by fecal microbiota transplantation

Differential Perturbations of Gut Microbial Profiles and Co-Occurrence Networks among Phases of Methamphetamine-Induced Conditioned Place Preference

Gut Microbiota Analysis in Rats with Methamphetamine-Induced Conditioned Place Preference

Alterations in Regional Homogeneity of Resting-State Brain Activity in Ketamine Addicts

Higher Glutamatergic Activity in the Medial Prefrontal Cortex in Chronic Ketamine Users

The effects of ketamine and methamphetamine on neurotransmitters, glutamate receptors, and conditioned place preference in rat

Alterations in Gut Microbiota Affect Behavioral and Inflammatory Responses to Methamphetamine in Mice

Gut Dysbiosis Associated with the Rats' Responses in Methamphetamine‐induced Conditioned Place Preference

Repeated ketamine anesthesia during neurodevelopment upregulates hippocampal activity and enhances drug reward in male mice

Differential alteration in gut microbiome profiles during acquisition, extinction and reinstatement of morphine-induced CPP

The role of the microbiota–gut–brain axis in methamphetamine-induced neurotoxicity: Disruption of microbial composition and short-chain fatty acid metabolism

Endocannabinoid Signaling Regulates the Reinforcing and Psychostimulant Effects of Ketamine in Mice.

Decreased Thalamocortical Connectivity in Chronic Ketamine Users

Microbial glutamate metabolism predicts intravenous cocaine self-administration in diversity outbred mice

Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties

Gut Microbiota is Involved in the Antidepressant-Like Effect of (S)-Norketamine in an Inflammation Model of Depression

Subanesthetic Dose of Ketamine Improved CFA-induced Inflammatory Pain and Depression-like Behaviors Via Caveolin-1 in Mice

Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP mice

Gut-derived bacterial LPS attenuates incubation of methamphetamine craving via modulating microglia

The microbial community dynamics of cocaine sensitization in two behaviorally divergent strains of collaborative cross mice